Make an Appointment
Online Schedule
ABOUT DOCTOR
Area of interest
*Thalassemia
*A bone marrow transplant
*Vascular disorders
*Childhood cancers
EDUCATION
*2000 – 2006 – Faculty of Medicine; Istanbul University – Cerrahpasa Faculty of Medicine
*2007 – 2012 – Specialized training in health and childhood diseases; Istanbul University – Cerrahpasa Faculty of Medicine
*2014 – 2018- Minor Specialization Training in Pediatric Hematology and Oncology – Istanbul University – Cerrahpaşa Faculty of Medicine
EXPERIENCES
*2012 – 2013 Erzincan Mengücek Gazi Training and Research Hospital, Pediatric Specialist
*2013 – 2014 Kocaeli University Neonatal Intensive Care Unit
*2018 – 2019 Altınbaş University Medical Park Bahçelievler Hospital, Pediatric Bone Marrow Transplant Unit
*2019 – 2022 Şanlıurfa Training and Research Hospital, Pediatric Hematology and Oncology Specialist
*2022 – Currently IAU VM Medical Park Florya Hospital
Dr.Gürcan Dikme
Thalassemia
Treatments during the year.
Marrow Transplantation
Treatments during the year.
Child Cancers
Treatments during the year.
Vascular Disorders
Treatments during the year.
*Member of Turkish Medical Association
*Member of Turkish Institute of Pediatrics
*Member of Turkish Society of Hematology
*Dikme G, Arvas A, Gür E. The relationship between blood lead levels and chronic
disease in children Turk Arch Ped 2013; 221-225.
*Celkan T, Dikme G. Thrombosis in children: Which test for whom, when and how
much is needed? Turk Pediatrics Ars 2018; 53:1-9
*Kızılocak H, Dikme G, Özdemir N, Kuruoğlu S, Adaletli İ, Erkan T, Celkan T.
Sinusoidal obstruction syndrome during pediatric cancer chemotherapy and its
successful management with defibrotide. J Pediatr Hematol Oncol.2017.39(7); 373-
376.
*Kızılocak H, Özdemir N, Dikme G, Koç B, Atabek AA, Çokuğraş H, İskeleli G, Dönmez-Demir B, Christiansen NM, Ziegler M, Ozdağ H, Schuster V, Celkan T. Frozen plasma
Pediatric blood and cancer. Vol.65, 2018
*Kızılocak H, Özdemir N, Dikme G, Koç B, Celkan T. Homozygous Protein C Deficiency
Presenting as Neonatal Purpura Fulminans; management with fresh frozen plasma,
low molecular weight heparin and protein C concentrate. J Thromb
Thrombolysis.2018,45; 315-318.
*Kizilocak H, Dikme G, Celkan T. Sirolimus Experience in Blue Rubber Bleb Nevus
Syndrome. Journal of Pediatric Hematol Oncol. 2018, 40; 168-169.
Kızılocak H, Özdemir N, Dikme G, Haşıloğlu ZI, Celkan T. Wernicke encephalopathy
in a child with acute lymphoblastic leukemia. Turkish J Hematol. 2017.34:99-117.
*Kızılocak H, Özdemir N, Varol F, Koç B, Dikme G, Çam H, Celkan T. Five-year-old girl
with bleeding tongue. Turk Pediatrics Ars. 2019, 51:117-119.
*Cipe FE, Aksoy BA, Aydogdu S, Dikme G, Kiykim A, Aydogmus C, Yucel E, Bozkurt C,
Fisgin T. Primary immunodeficiencies: HSCT experiences from a single center in
Turkey. Pediatric transplant. 2021;00:14063.
*Koç B, Dikme G, Özdemir N, Zülfikar B. A patient who presented with abdominal pain
and eosinophilia. Turk Pediatrics Ars 2016; 51:57-59
*2000 – 2006 – Faculty of Medicine; Istanbul University – Cerrahpasa Faculty of Medicine
*2007 – 2012 – Specialized training in health and childhood diseases; Istanbul University – Cerrahpasa Faculty of Medicine
*2014 – 2018- Minor Specialization Training in Pediatric Hematology and Oncology – Istanbul University – Cerrahpaşa Faculty of Medicine
*2012 – 2013 Erzincan Mengücek Gazi Training and Research Hospital, Pediatric Specialist
*2013 – 2014 Kocaeli University Neonatal Intensive Care Unit
*2018 – 2019 Altınbaş University Medical Park Bahçelievler Hospital, Pediatric Bone Marrow Transplant Unit
*2019 – 2022 Şanlıurfa Training and Research Hospital, Pediatric Hematology and Oncology Specialist
*2022 – Currently IAU VM Medical Park Florya Hospital